Loading
Open Search
DIR028084Merck & Co., Inc. Kenilworth, N.J., U.S.A. known as Merck in the United States and Canada, is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. The difference .....
DescriptionAn oncology MSL will, with a high level of proficiency, develop and maintain professional relationships with prominent healthcare providers and key decision makers as they relate to Eisai’s products. The candidate in this position will .....
DIR028062Merck & Co., Inc. Kenilworth, N.J., U.S.A. known as Merck in the United States and Canada, is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. The difference .....
summarythis position is for sr. specialty Retail Sales representative located in cleveland west. sales candidates must be able to understand and apply knowledge of pertinent Health Care industry trends, sales trends, market dynamics, competitors, .....
Medical Science Liaison (MSL) - Rare DiseaseThe Medical Science Liaison (MSL) will be responsible for providing non-promotional scientific, educational, and research support for the Genzyme Rare Disease portfolio in the respective territory. The .....
primary role: the northeast regional disease Education manager (rdem) is responsible for the implementation of the strategic initiatives developed by the Leadership team. the rdem will educate and raise awareness of specific lysosomal storage .....
DescriptionAn oncology MSL will, with a high level of proficiency, develop and maintain professional relationships with prominent healthcare providers and key decision makers as they relate to Eisai’s products. The candidate in this position will .....
Medical Science Liaison (MSL) - Rare Disease - Midwest Region (MI, WI, IN IA) - United States
Sanofigenzyme 8
Responsibilities Medical Science Liaison (MSL) - Rare DiseaseThe Medical Science Liaison (MSL) will be responsible for providing non-promotional scientific, educational, and research support for the Genzyme Rare Disease portfolio in the respective .....